Scholars Central

Research articlePublished 2013

Nimesulide and Celecoxib Inhibits Multiple Oncogenic Pathways in Gastric Cancer Cells

Authors: Jayaprakash Periasamy, Muthulakshmi Muthuswami, Vignesh Ramesh, Thangaselvam Muthusamy, Amrita Jain, Chandrabose Karthikeyan, Piyush Trivedi, Rayala Suresh Kumar, Paramasamy Gunasekaran, Sun Young Rha, Partick Tan, Ganesan Kumaresan

Cancer Science & Therapy

Volume 5 · Issue 4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Despite being the leading cause of cancer death, targeted therapy for gastric cancer is yet to be established. Wnt/β-catenin signaling is highly deregulated in cancers of gastrointestinal origin including gastric cancers. Stabilization and deregulation of β-catenin occurs at multiple levels and so is being needed to identify a spectrum of Wnt inhibitors to combat deregulated Wnt signaling at the level of various targets and also in different combinations. We developed a luciferase reporter based gastric cancer cellular assay system for Wnt pathway modulator screening and identified nimesulide, a known COX-2 inhibitor as an inhibitor of Wnt/β catenin signaling pathway. Comprehensive signaling pathway profiling revealed that nimesulide could inhibit STAT3, IRF1 and RXR signaling apart from inhibiting Wnt/β-catenin-Myc-E2F signaling cascade. Nimesulide elicits a strong anti-proliferative effect by promoting cell cycle arrest in multiple gastric cancer cell lines. Inhibition of Wnt and STAT3 signaling are found to be COX-2 independent, while the inhibition of RXR and IRF1 pathways are due to the COX-2 inhibiting feature of nimesulide. While nimesulide is capable of activating Notch signaling in gastric cancer cells, celecoxib inhibits Wnt, Myc, E2F, RXR, STAT3, MAPK and Notch signaling pathways in gastric cancer cells. Signaling pathway focused analysis of gastric cancer transcriptome revealed that Wnt, STAT3, IRF1 and RXR signaling pathway are highly deregulated in majority of gastric tumors and indicates the potential of nimesulide and celecoxib class of drugs for targeted gastric cancer therapeutics. The differential inhibition of multiple signaling by nimesulide and celecoxib deserve further investigation.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Jayaprakash Periasamy”
  • BylineArticles whose byline prints “Muthulakshmi Muthuswami”
  • BylineArticles whose byline prints “Vignesh Ramesh”
  • BylineArticles whose byline prints “Thangaselvam Muthusamy”
  • BylineArticles whose byline prints “Amrita Jain”
  • BylineArticles whose byline prints “Chandrabose Karthikeyan”
  • BylineArticles whose byline prints “Piyush Trivedi”
  • BylineArticles whose byline prints “Rayala Suresh Kumar”